| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P2093 | author name string | Yan Tang | |
| Masuko Ushio-Fukai | |||
| Mitsuaki Fujimoto | |||
| Tohru Fukai | |||
| Chad Johnson | |||
| R. Wayne Alexander | |||
| Patrick J. Pagano | |||
| Yuxian Ma | |||
| Mark T. Quinn | |||
| Sergey I. Dikalov | |||
| P2860 | cites work | Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells | Q77759136 |
| On the possible role of reactive oxygen species in angiogenesis | Q77797946 | ||
| Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production | Q28114945 | ||
| Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells | Q28566071 | ||
| NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
| Signal transduction by reactive oxygen species in non-phagocytic cells. | Q33542052 | ||
| Novel homologs of gp91phox. | Q34069745 | ||
| Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors | Q34126142 | ||
| The NADPH oxidase of endothelial cells | Q34235453 | ||
| Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries | Q36688465 | ||
| Protection from reoxygenation injury by inhibition of rac1. | Q37381258 | ||
| Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells | Q38327866 | ||
| Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. | Q43576435 | ||
| Vascular endothelial growth factor induces manganese‐superoxide dismutase expression in endothelial cells by a Racl‐regulated NADPH oxidase‐dependent mechanism | Q43771298 | ||
| Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. | Q43806613 | ||
| Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine | Q44018844 | ||
| Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. | Q44028496 | ||
| Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds | Q46469206 | ||
| A Rac1 Effector Site Controlling Mitogenesis through Superoxide Production | Q47860128 | ||
| p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy | Q48010552 | ||
| Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. | Q52537902 | ||
| A gp91phox Containing NADPH Oxidase Selectively Expressed in Endothelial Cells Is a Major Source of Oxygen Radical Generation in the Arterial Wall | Q60723097 | ||
| The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide | Q64380055 | ||
| Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol | Q72031040 | ||
| NADPH oxidase activity is required for endothelial cell proliferation and migration | Q73303463 | ||
| Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis | Q73454257 | ||
| P433 | issue | 12 | |
| P921 | main subject | endothelium | Q111140 |
| angiogenesis | Q539568 | ||
| P304 | page(s) | 1160–1167 | |
| P577 | publication date | 2002-12-13 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis | |
| P478 | volume | 91 |
| Q37974024 | 20-HETE in neovascularization |
| Q42098014 | 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells. |
| Q37138971 | 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells |
| Q87680073 | A Chinese 2-herb formula (NF3) promotes hindlimb ischemia-induced neovascularization and wound healing of diabetic rats |
| Q33648934 | A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes |
| Q44391230 | A radical adventure: the quest for specific functions and inhibitors of vascular NAPDH oxidases |
| Q42538987 | A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids |
| Q40563957 | Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress |
| Q34571046 | Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion |
| Q46759092 | Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells |
| Q80782253 | Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice |
| Q44799753 | Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. |
| Q36906269 | Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease? |
| Q46622856 | Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report |
| Q42096169 | Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies |
| Q83133100 | An arylidene-thiazolidinedione derivative, GPU-4, without PPARγ activation, reduces retinal neovascularization |
| Q37287612 | An ezrin/calpain/PI3K/AMPK/eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production |
| Q80363039 | Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase |
| Q43148412 | Angiogenesis and blood vessel stability in inflammatory arthritis |
| Q50328661 | Angiogenesis modulation by exogenous antioxidants |
| Q26777977 | Angiomodulatory properties of Rhodiola spp. and other natural antioxidants |
| Q80340580 | Angiopoietin-1 attenuates H2O2-induced SEK1/JNK phosphorylation through the phosphatidylinositol 3-kinase/Akt pathway in vascular endothelial cells |
| Q28508304 | Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo |
| Q83297534 | Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase |
| Q48582431 | Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β. |
| Q38924590 | Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling |
| Q53355953 | Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production |
| Q39348667 | Anti-metastatic and anti-angiogenic properties of potential new anti-cancer drugs based on metal complexes of selenosemicarbazones |
| Q46432420 | Antiangiogenic activity of 4-O-methylgallic acid from Canavalia gladiata, a dietary legume |
| Q42838837 | Antiatherogenic effect of bisvanillyl-hydralazone, a new hydralazine derivative with antioxidant, carbonyl scavenger, and antiapoptotic properties. |
| Q38501183 | Antioxidant Therapy: Is it your Gateway to Improved Cardiovascular Health? |
| Q85245597 | Antioxidant and antiangiogenic properties of phenolic extract from Pleurotus tuber-regium |
| Q44948972 | Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs |
| Q45006846 | Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. |
| Q45290155 | Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity |
| Q39153631 | Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation. |
| Q37164272 | Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling |
| Q44725177 | Assessment of renal functional phenotype in mice lacking gp91PHOX subunit of NAD(P)H oxidase |
| Q34586951 | Association between NADPH Oxidase p22phox C242T Polymorphism and Ischemic Cerebrovascular Disease: A Meta-Analysis |
| Q36017360 | Association of the NAD(P)H oxidase p22 phox gene C242T polymorphism with type 2 diabetes mellitus, diabetic nephropathy, and carotid atherosclerosis with type 2 diabetes mellitus: A meta-analysis |
| Q30886863 | Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells |
| Q45855269 | Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis |
| Q41904227 | Bidirectional interactions between NOX2-type NADPH oxidase and the F-actin cytoskeleton in neuronal growth cones |
| Q38159735 | Bioactive lipids in pathological retinopathy |
| Q26991619 | Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system |
| Q31146191 | Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice |
| Q39184446 | Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site. |
| Q46856589 | Bone morphogenic protein-4-induced oxidant signaling via protein carbonylation for endothelial dysfunction. |
| Q55041823 | Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. |
| Q34987834 | Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma |
| Q30539574 | Cell-trappable fluorescent probes for endogenous hydrogen sulfide signaling and imaging H2O2-dependent H2S production. |
| Q28397579 | Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer |
| Q34297316 | Cerebral amyloid angiopathy impact on endothelium |
| Q92486308 | Cerebrovascular inflammation: A critical trigger for neurovascular injury? |
| Q83514147 | Changes by tacrolimus of the rat aortic proteome: involvement of endothelin-1 |
| Q46617718 | Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition |
| Q45235332 | Circulating progenitor cells and the elderly: a seven-year observational study. |
| Q62030629 | Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness |
| Q45335007 | Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. |
| Q38324442 | Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies |
| Q46578290 | Comparison of cardioprotective effects using salvianolic acid B and benazepril for the treatment of chronic myocardial infarction in rats |
| Q46409865 | Comparison of the signaling mechanisms by which VEGF, H2O2, and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase |
| Q37322476 | Compartmentalization of redox signaling through NADPH oxidase-derived ROS. |
| Q93020905 | Concomitant overexpression of triple antioxidant enzymes selectively increases circulating endothelial progenitor cells in mice with limb ischaemia |
| Q37418503 | Coordinated role of voltage-gated sodium channels and the Na+/H+ exchanger in sustaining microglial activation during inflammation. |
| Q26772290 | Critical Roles of Reactive Oxygen Species in Age-Related Impairment in Ischemia-Induced Neovascularization by Regulating Stem and Progenitor Cell Function |
| Q46380299 | Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity |
| Q38132120 | Current status of NADPH oxidase research in cardiovascular pharmacology |
| Q52925752 | Deficient angiogenesis in redox-dead Cys17Ser PKARIα knock-in mice |
| Q33649275 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. |
| Q27322671 | Differential regulation of TRPV1 channels by H2O2: implications for diabetic microvascular dysfunction. |
| Q37971795 | Differential roles of NADPH oxidases in vascular physiology and pathophysiology |
| Q37260191 | Differential vascular functions of Nox family NADPH oxidases |
| Q34092503 | Direct Sensing of Endothelial Oxidants by Vascular Endothelial Growth Factor Receptor-2 and c-Src |
| Q37941867 | Do statins have a role in reduction/prevention of post-PCI restenosis? |
| Q33818148 | Downstream targets and intracellular compartmentalization in Nox signaling |
| Q39057795 | ETS transcription factor ETV2/ER71/Etsrp in hematopoietic and vascular development, injury, and regeneration |
| Q39830292 | Early signaling by vascular endothelial growth factor and placental growth factor in human bone marrow-derived endothelial cells is mediated by superoxide |
| Q35971126 | Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets |
| Q33914406 | Effects of Aging on Angiogenesis |
| Q42203698 | Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats |
| Q64098721 | Effects of bradykinin on the survival of multiterritory perforator flaps in rats |
| Q36432630 | Effects of calcitriol on random skin flap survival in rats |
| Q39938495 | Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NAD(P)H subunit p22phox |
| Q47108920 | Effects of puerarin on the retina and STAT3 expression in diabetic rats |
| Q37812765 | Effects of resveratrol and other wine polyphenols on vascular function: an update |
| Q28588321 | Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome |
| Q36042713 | Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases |
| Q35947546 | Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing |
| Q42798882 | Endothelial Progenitor Cells=EPC=Elemental Pernicious Complexity |
| Q37223876 | Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration |
| Q35913809 | Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. |
| Q37125689 | Endothelial signaling in paracellular and transcellular leukocyte transmigration |
| Q30496168 | Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species |
| Q36977680 | Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. |
| Q33666049 | Essential Role of Copper-Zinc Superoxide Dismutase for Ischemia-Induced Neovascularization Via Modulation of Bone Marrow–Derived Endothelial Progenitor Cells |
| Q33761211 | European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). |
| Q39407718 | Evaluation of cellular response to perfluorooctane sulfonate in human umbilical vein endothelial cells. |
| Q38041505 | Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. |
| Q33205904 | Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and -independent mechanisms |
| Q37467798 | Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. |
| Q33565541 | Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice |
| Q37576023 | Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice. |
| Q24312013 | Fibulin-5 is a novel binding protein for extracellular superoxide dismutase |
| Q37191663 | Function of reactive oxygen species during animal development: passive or active? |
| Q40195197 | Functional implication of BMP4 expression on angiogenesis in malignant melanoma |
| Q28199073 | Functional role of NADPH oxidase in activation of platelets |
| Q38253183 | Gene therapy for chronic granulomatous disease: current status and future perspectives. |
| Q42452009 | Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells |
| Q30939997 | Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis |
| Q37415671 | Glutathione peroxidases in different stages of carcinogenesis |
| Q43470500 | Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore |
| Q34894079 | Grifola frondosa (maitake mushroom) water extract inhibits vascular endothelial growth factor-induced angiogenesis through inhibition of reactive oxygen species and extracellular signal-regulated kinase phosphorylation |
| Q28538396 | HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway |
| Q33641974 | HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy. |
| Q82471490 | Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats |
| Q37559355 | Hemorrhagic transformation after ischemic stroke in animals and humans |
| Q54635450 | Hepatocyte growth factor induces a proangiogenic phenotype and mobilizes endothelial progenitor cells by activating Nox2. |
| Q45881660 | Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence |
| Q42906480 | High DNA oxidative damage in systemic sclerosis |
| Q28180577 | Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo |
| Q34379685 | Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells |
| Q37461694 | Hyaluronic Acid Promotes Angiogenesis by Inducing RHAMM-TGFβ Receptor Interaction via CD44-PKCδ |
| Q37849782 | Hydrogen peroxide as a signaling molecule |
| Q64377732 | Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis |
| Q38196405 | Hydrogen peroxide signaling in vascular endothelial cells. |
| Q39485361 | Hydrogen peroxide signaling mediates DHEA-induced vascular endothelial cell proliferation |
| Q38844323 | Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis |
| Q64378699 | ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells |
| Q53618817 | IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis |
| Q46716879 | IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. |
| Q44951935 | IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation. |
| Q39964836 | Identification of a rare subset of adipose tissue-resident progenitor cells, which express CD133 and TRPC3 as a VEGF-regulated Ca2+ entry channel. |
| Q36313378 | Impact of oxidized low density lipoprotein on vascular cells |
| Q37762813 | Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway |
| Q38087157 | Importance of insulin resistance to vascular repair and regeneration |
| Q80838573 | Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro |
| Q45190378 | In vivo expression of recombinant vascular endothelial growth factor in rabbit carotid artery increases production of superoxide anion |
| Q34527211 | Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization |
| Q38293179 | Induction of hypoxia-inducible factor 1alpha gene expression by vascular endothelial growth factor |
| Q44436286 | Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation? |
| Q46001182 | Inhibiting the response to VEGF in diabetes. |
| Q35085027 | Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. |
| Q54382604 | Inhibition of hypoxia-induced retinal neovascularization in mice with short hairpin RNA targeting Rac1, possibly via blockading redox signaling |
| Q44628537 | Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. |
| Q45983209 | Inhibitory actions of bilberry anthocyanidins on angiogenesis. |
| Q52844300 | Insulin- and Growth Factor-Resistance Impairs Vascular Regeneration in Diabetes Mellitus |
| Q44477930 | Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease |
| Q50971853 | Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein |
| Q42973581 | Intracellular Ca2+ can compensate for the lack of NADPH oxidase-derived ROS in endothelial cells |
| Q38730377 | Intracellular cysteine oxidation is modulated by aquaporin-8-mediated hydrogen peroxide channeling in leukaemia cells. |
| Q36954247 | Involvement of NADPH oxidases in cardiac remodelling and heart failure. |
| Q40338844 | Involvement of phosphoinositide 3-kinase class IA (PI3K 110α) and NADPH oxidase 1 (NOX1) in regulation of vascular differentiation induced by vascular endothelial growth factor (VEGF) in mouse embryonic stem cells |
| Q40303320 | Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis |
| Q37690990 | Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature |
| Q48599380 | Lectin-like Oxidized Low-density Lipoprotein Receptor-1 (LOX-1) and Cardiac Fibroblast Growth |
| Q46793312 | Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX. |
| Q61841565 | Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9 |
| Q37965449 | Less stress, more success? Oncological implications of surgery-induced oxidative stress. |
| Q36936487 | Localized cysteine sulfenic acid formation by vascular endothelial growth factor: role in endothelial cell migration and angiogenesis |
| Q36574300 | Localizing NADPH oxidase-derived ROS. |
| Q46656372 | Lung endothelial cell proliferation with decreased shear stress is mediated by reactive oxygen species |
| Q44890498 | Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells |
| Q46552044 | Mechanisms for suppressing NADPH oxidase in the vascular wall |
| Q46743727 | Methods in the evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress |
| Q37322333 | Microglial ion channels as potential targets for neuroprotection in Parkinson's disease |
| Q46006832 | Microparticles from ischemic muscle promotes postnatal vasculogenesis. |
| Q44895732 | Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling |
| Q35103539 | Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling |
| Q91189456 | Mitochondrial dysfunction in rheumatoid arthritis: A comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data |
| Q46432453 | Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium. |
| Q33572306 | Molecular regulation of tumor angiogenesis and perfusion via redox signaling |
| Q54495622 | Monocyte chemotactic protein-induced protein (MCPIP) promotes inflammatory angiogenesis via sequential induction of oxidative stress, endoplasmic reticulum stress and autophagy |
| Q37076834 | Mouse models for preeclampsia: disruption of redox-regulated signaling |
| Q38521718 | Multi-layered representation for cell signaling pathways. |
| Q36311166 | Multifocal angiostatic therapy: an update |
| Q35624665 | N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase. |
| Q35761411 | NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. |
| Q41554019 | NADPH Oxidase 4 Promotes Endothelial Angiogenesis Through Endothelial Nitric Oxide Synthase Activation |
| Q50297912 | NADPH oxidase 2 (NOX2) complex binds RAC1 |
| Q39713250 | NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. |
| Q28264121 | NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases |
| Q43292284 | NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells |
| Q46972328 | NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways |
| Q36232155 | NADPH oxidase and endothelial cell function |
| Q46065944 | NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. |
| Q36656609 | NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation |
| Q37449222 | NADPH oxidase signaling and cardiac myocyte function. |
| Q33632781 | NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy |
| Q37265507 | NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology |
| Q41089726 | NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. |
| Q41786123 | NADPH oxidase-generated reactive oxygen species are required for stromal cell-derived factor-1α-stimulated angiogenesis |
| Q38054458 | NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury |
| Q37974319 | NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts |
| Q37742824 | NADPH oxidases in cardiovascular disease. |
| Q35145985 | NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. |
| Q36505570 | NADPH oxidases in cardiovascular health and disease |
| Q36571169 | NADPH oxidases in lung biology and pathology: host defense enzymes, and more |
| Q33632089 | NADPH oxidases in vascular pathology |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q33739287 | NADPH oxidases: functions and pathologies in the vasculature |
| Q33649864 | NOX enzymes and pulmonary disease |
| Q40229689 | NOX2 and NOX4 mediate proliferative response in endothelial cells. |
| Q59128438 | NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development |
| Q24295185 | NOX5 variants are functionally active in endothelial cells |
| Q35862506 | Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase |
| Q36230886 | New insights on oxidative stress in the artery wall. |
| Q36317506 | Nicotinamide adenine dinucleotide phosphate oxidase: a promiscuous therapeutic target for cardiovascular drugs? |
| Q34391024 | Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q39261217 | Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation |
| Q35964916 | Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells |
| Q37852399 | Nox enzymes in allergic airway inflammation |
| Q38243365 | Nox family NADPH oxidases: Molecular mechanisms of activation |
| Q34577042 | Nox2 is required for macrophage chemotaxis towards CSF-1. |
| Q41268543 | Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53 |
| Q45941582 | Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. |
| Q34597540 | Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-α-induced apoptosis |
| Q34264162 | Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase |
| Q42177157 | Nox4- and Nox2-dependent oxidant production is required for VEGF-induced SERCA cysteine-674 S-glutathiolation and endothelial cell migration |
| Q35929722 | OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model |
| Q79793883 | Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth |
| Q31025245 | Overexpression of catalase in myeloid cells causes impaired postischemic neovascularization. |
| Q79346091 | Oxidant signaling in lung cells |
| Q36136532 | Oxidant stress in renal pathophysiology |
| Q54162627 | Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint |
| Q36953696 | Oxidative stress impairs endothelial progenitor cell function |
| Q42589408 | Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. |
| Q37535220 | Oxidative stress in angiogenesis and vascular disease |
| Q34000654 | Oxidative stress promotes ocular neovascularization. |
| Q35903570 | Oxygen free radicals and redox biology of organelles |
| Q38208146 | Paradoxical action of reactive oxygen species in creation and therapy of cancer |
| Q35573957 | Pathophysiological aspects of cellular pyridine nucleotide metabolism: focus on the vascular endothelium. Review |
| Q36129229 | Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitamins |
| Q37889557 | Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-. |
| Q33599707 | Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects |
| Q46800337 | Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species |
| Q56742829 | Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells |
| Q38931047 | Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation |
| Q46525971 | Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice |
| Q46038701 | Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. |
| Q46076554 | Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties |
| Q44711333 | Platelets induce reactive oxygen species-dependent growth of human skin fibroblasts |
| Q36248631 | Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. |
| Q37077934 | Post-ischaemic neovascularization and inflammation |
| Q38153677 | Postischemic revascularization: from cellular and molecular mechanisms to clinical applications |
| Q43282978 | Probucol and antioxidant vitamins rescue ischemia-induced neovascularization in mice exposed to cigarette smoke: potential role of endothelial progenitor cells |
| Q33632180 | Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body. |
| Q47762178 | Protective Effect of Combined Caffeic Acid Phenethyl Ester and Bevacizumab Against Hydrogen Peroxide-Induced Oxidative Stress in Human RPE Cells |
| Q45785313 | Protein kinase C-delta mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine |
| Q53573779 | Proteomic analysis of tyrosine phosphorylations in vascular endothelial growth factor- and reactive oxygen species-mediated signaling pathway |
| Q106518963 | RAC1 binds effectors at the plasma membrane |
| Q45318323 | RHO GTPases Activate NADPH Oxidases |
| Q28396460 | ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology |
| Q44628944 | Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells |
| Q42489769 | Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension |
| Q34197794 | Rac1-Dependent Intracellular Superoxide Formation Mediates Vascular Endothelial Growth Factor–Induced Placental Angiogenesis in Vitro |
| Q36368626 | Rapid actions of aldosterone in vascular health and disease--friend or foe? |
| Q50053776 | Reactive Oxygen Species Play a Biphasic Role in Brain Ischemia |
| Q45834311 | Reactive Oxygen Species and NOX Enzymes Are Emerging as Key Players in Cutaneous Wound Repair |
| Q60731459 | Reactive Oxygen Species in Physiologic and Pathologic Angiogenesis |
| Q36587602 | Reactive Oxygen Species in Vascular Formation and Development |
| Q36770038 | Reactive oxygen and nitrogen species: implications for cardiovascular device engineering |
| Q37135987 | Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy |
| Q35845567 | Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease |
| Q34757570 | Reactive oxygen species and endothelial activation |
| Q35949648 | Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase |
| Q36342607 | Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis |
| Q38122186 | Reactive oxygen species in cancer biology and anticancer therapy |
| Q35569201 | Reactive oxygen species in the vasculature: molecular and cellular mechanisms |
| Q36510294 | Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1. |
| Q45931818 | Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney. |
| Q40267905 | Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells |
| Q34227711 | Reactive oxygen species regulate osteopontin expression in a murine model of postischemic neovascularization. |
| Q27332266 | Reactive oxygen species regulate protrusion efficiency by controlling actin dynamics |
| Q46903669 | Reactive oxygen species regulate the quiescence of CD34-positive cells derived from human embryonic stem cells |
| Q38078985 | Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy |
| Q35888592 | Reactive oxygen species-mediated signal transduction in the endothelium |
| Q37721558 | Reactive oxygen species: A radical role in development? |
| Q38217380 | Reactive oxygen species: physiological roles in the regulation of vascular cells |
| Q37650551 | Receptor activation of NADPH oxidases |
| Q98474971 | Recruitment and Maturation of the Coronary Collateral Circulation: Current Understanding and Perspectives in Arteriogenesis |
| Q39059046 | Redox Control of Skeletal Muscle Regeneration. |
| Q37860340 | Redox Control of the Survival of Healthy and Diseased Cells |
| Q96836073 | Redox Regulation of NOX Isoforms on FAK(Y397)/SRC(Y416) Phosphorylation Driven Epithelial-to-Mesenchymal Transition in Malignant Cervical Epithelial Cells |
| Q27004547 | Redox balance dynamically regulates vascular growth and remodeling |
| Q40450443 | Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. |
| Q37245109 | Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. |
| Q34298394 | Redox regulation of cancer cell migration and invasion |
| Q35889032 | Redox regulation of cell migration and adhesion |
| Q39256530 | Redox regulation of gasotransmission in the vascular system: A focus on angiogenesis |
| Q35174581 | Redox regulation of protein kinases |
| Q37055806 | Redox regulation of the VEGF signaling path and tissue vascularization: Hydrogen peroxide, the common link between physical exercise and cutaneous wound healing |
| Q36509981 | Redox signaling in angiogenesis: role of NADPH oxidase |
| Q93227644 | Redox signaling in the pathogenesis of human disease and the regulatory role of autophagy |
| Q36628663 | Redox signalling involving NADPH oxidase-derived reactive oxygen species |
| Q37076810 | Redox signals in wound healing |
| Q40229694 | Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells |
| Q33765463 | Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis |
| Q35608868 | Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension |
| Q46468624 | Reducing oxidized lipids to prevent cardiovascular disease |
| Q33772560 | Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins |
| Q36412266 | Regulation of NADPH oxidases: the role of Rac proteins |
| Q37414487 | Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering |
| Q37826870 | Regulation of myocardial growth and death by NADPH oxidase |
| Q35651532 | Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer |
| Q79460195 | Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages |
| Q36097870 | Resveratrol: preventing properties against vascular alterations and ageing |
| Q33641986 | Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. |
| Q46411412 | Role of NADPH oxidase in tissue growth in a tissue engineering chamber in rats |
| Q35895542 | Role of autophagy in angiogenesis in aortic endothelial cells |
| Q31167736 | Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. |
| Q37691607 | Role of metabolic H2O2 generation: redox signaling and oxidative stress |
| Q42535142 | Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia |
| Q29617974 | Role of oxidative modifications in atherosclerosis |
| Q37045445 | Role of oxidative stress and nitric oxide in atherothrombosis |
| Q42199994 | Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells |
| Q35572612 | Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension |
| Q42481813 | Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. |
| Q85071634 | Rosiglitazone, a PPAR-γ agonist, inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes |
| Q54493403 | S-Glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration |
| Q39700512 | S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration |
| Q46129058 | SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties |
| Q37313563 | Selective targeting of NADPH oxidase for cardiovascular protection |
| Q46590490 | Senescence marker protein-30 deficiency impairs angiogenesis under ischemia |
| Q37094609 | Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species |
| Q92204043 | Skeletal muscle-derived exosomes regulate endothelial cell functions via reactive oxygen species-activated nuclear factor-κB signalling |
| Q80838580 | Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway |
| Q36118494 | Specificity in reactive oxidant signaling: think globally, act locally |
| Q28576634 | Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells |
| Q36320521 | Subcellular targeting of oxidants during endothelial cell migration |
| Q37394541 | Superoxide dismutase1 levels in North Indian population with age-related macular degeneration |
| Q37138949 | Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth |
| Q35888581 | Suppression of oxidative stress in the endothelium and vascular wall |
| Q46425143 | TFEB inhibits endothelial cell inflammation and reduces atherosclerosis |
| Q50658306 | TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells |
| Q36398049 | Targeting reactive oxygen species in hypertension |
| Q37781872 | Targeting tissue oxidative damage by means of cell signaling modulators: The antioxidant concept revisited |
| Q28743072 | Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism |
| Q28304274 | The A930G polymorphism ofP22phox (CYBA) gene but not C242T variation is associated with hypertension: a meta-analysis |
| Q52331695 | The Antioxidant Therapy: New Insights in the Treatment of Hypertension. |
| Q83594973 | The HIF1 target geneNOX2promotes angiogenesis through urotensin-II |
| Q39306993 | The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis. |
| Q53659763 | The NADPH Oxidase Nox4 mediates tumour angiogenesis |
| Q27860991 | The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology |
| Q39028636 | The Pathophysiological Role of NOX2 in Hypertension and Organ Damage |
| Q26741231 | The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm |
| Q104102211 | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury |
| Q104488857 | The Relationship Between Reactive Oxygen Species and Endothelial Cell Metabolism |
| Q38151364 | The Yin and Yang of redox regulation. |
| Q36931118 | The albino mutation of tyrosinase alters ocular angiogenic responsiveness |
| Q54540532 | The anti-angiogenic and anti-tumor activity of synthetic phenylpropenone derivatives is mediated through the inhibition of receptor tyrosine kinases |
| Q46207244 | The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling |
| Q36501615 | The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction |
| Q31145053 | The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells |
| Q34276805 | The general case for redox control of wound repair |
| Q53381128 | The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis |
| Q37377623 | The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species |
| Q46913012 | The regulatory effect of norepinephrine on connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF) expression in cultured cardiac fibroblasts |
| Q46489830 | The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells |
| Q40422869 | The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation |
| Q30824712 | The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases |
| Q84260009 | Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species |
| Q28586447 | Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation |
| Q35867960 | Transforming growth factor-β1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo |
| Q43274985 | Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells |
| Q38205041 | Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets. |
| Q35159432 | Unforeseen decreases in dissolved oxygen levels affect tube formation kinetics in collagen gels |
| Q40290581 | Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes |
| Q36825904 | VEGF signaling through NADPH oxidase-derived ROS. |
| Q36450466 | VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction |
| Q42009141 | Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo |
| Q35175526 | Vascular NAD(P)H oxidases: specific features, expression, and regulation |
| Q35994483 | Vascular NADPH oxidases: molecular mechanisms of activation. |
| Q34280300 | Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. |
| Q33219756 | Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress |
| Q30961526 | Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q40526010 | Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. |
| Q33112683 | Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor |
| Q35950277 | Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide |
| Q24316420 | Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis |
| Q87820292 | [ROS and NADPH oxidase: key regulators of tumor vascularisation] |
| Q44478660 | c-Src and smooth muscle NAD(P)H oxidase: assembling a path to hypertrophy |
| Q36302954 | eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage |
Search more.